Last reviewed · How we verify

NCT06551714

The Effect of Neurophysiological Facilitation Techniques on Health Parameters in Early Stages After Open Heart Surgery

Recruiting now NA Last updated 13 August 2024
What this trial tests

NA trial testing Phase 1 cardiac rehabilitation in Open Heart Surgery in 32 participants. Currently enrolling.

Timeline
1 January 2024
Primary endpoint
1 October 2024
1 November 2024

Quick facts

Lead sponsorDogus Universitesi
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment32
Start date1 January 2024
Primary completion1 October 2024
Estimated completion1 November 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Dogus Universitesi

Who can join

Adults 18 to 75, any sex, with Open Heart Surgery or Cardiovascular Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, researchers aimed to investigate effects of neurophysiological facilitation on functional capacity and respiratory parameters of patients who underwent open heart surgery. Do neurophysiological facilitation techniques improve individuals' respiratory parameters more than phase 1 cardiac rehabilitation? Do neurophysiological facilitation techniques improve individuals' functional capacity more than phase 1 cardiac rehabilitation? Researchers will apply phase 1 cardiac rehabilitation to both groups to see the effectiveness of neurophysiological facilitation techniques.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Open Heart Surgery

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06551714.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing